{"id":"all-participants-aviane","safety":{"commonSideEffects":[{"rate":"10-15","effect":"Nausea"},{"rate":"5-10","effect":"Headache"},{"rate":"5-10","effect":"Breast tenderness"},{"rate":"5-10","effect":"Breakthrough bleeding"},{"rate":"2-5","effect":"Mood changes"},{"rate":"0.3-0.4","effect":"Venous thromboembolism"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Aviane contains a synthetic estrogen (ethinyl estradiol) and a progestin (levonorgestrel) that work together to inhibit the luteinizing hormone (LH) surge required for ovulation. The progestin component also thickens cervical mucus to impede sperm penetration and alters the endometrium to prevent implantation. This multi-mechanism approach provides contraceptive efficacy when taken daily.","oneSentence":"Aviane is an oral contraceptive that prevents pregnancy by suppressing ovulation through a combination of ethinyl estradiol and levonorgestrel.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:27:00.948Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Contraception (prevention of pregnancy)"}]},"trialDetails":[{"nctId":"NCT07013643","phase":"PHASE1","title":"A Study to Investigate the Effect of AZD6234, AZD9550, and a Combination of AZD9550 and AZD6234 on Pharmacokinetics of Combined Oral Contraceptive Ethinyl Estradiol/Levonorgestrel in Healthy Female Participants Living With Overweight or Obesity","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2025-06-04","conditions":"Healthy Participants","enrollment":75},{"nctId":"NCT07338955","phase":"","title":"Validating and Assessing Reliability","status":"RECRUITING","sponsor":"Bahria University","startDate":"2025-11-03","conditions":"Upper Limb Disability","enrollment":385},{"nctId":"NCT03249402","phase":"PHASE1","title":"A Study to Evaluate the Effect of Multiple Oral Doses of JNJ-42847922 on the Steady-state Pharmacokinetics of an Oral Contraceptive Containing Ethinyl Estradiol and Levonorgestrel in Healthy Female Adult Participants","status":"COMPLETED","sponsor":"Janssen-Cilag International NV","startDate":"2017-08-14","conditions":"Healthy","enrollment":24},{"nctId":"NCT06671405","phase":"PHASE1","title":"An Open-label Study in Healthy Participants to Evaluate AZD0780 as an Object or Precipitant of CYP3A4-mediated Drug-drug Interactions","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2024-09-25","conditions":"Dyslipidaemia","enrollment":59},{"nctId":"NCT06783192","phase":"PHASE1","title":"A Drug-Drug Interaction Study of MK 8527 With a Combined Oral Contraceptive (LNG/EE)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2023-08-14","conditions":"Human Immunodeficiency Virus (HIV), HIV Pre-Exposure Prophylaxis","enrollment":14},{"nctId":"NCT02531321","phase":"PHASE4","title":"Protease Inhibitors and Combined Oral Contraceptive Pharmacokinetics and Pharmacodynamics","status":"TERMINATED","sponsor":"University of Southern California","startDate":"2015-08","conditions":"Contraception, HIV","enrollment":17},{"nctId":"NCT01170390","phase":"PHASE4","title":"Oral Contraceptives and Body Mass Index","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2009-09","conditions":"Body Weight, Contraceptive Usage","enrollment":32}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Levonorgestrel and Ethinyl Estradiol"],"phase":"marketed","status":"active","brandName":"All participants (Aviane)","genericName":"All participants (Aviane)","companyName":"Oregon Health and Science University","companyId":"oregon-health-and-science-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Aviane is an oral contraceptive that prevents pregnancy by suppressing ovulation through a combination of ethinyl estradiol and levonorgestrel. Used for Contraception (prevention of pregnancy).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}